A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)

Clinical trial NCT01825785 · COMPLETED

Trial details

NCT number: NCT01825785
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postmenopausal Osteopenia

Start date: 2007-11-14
Primary completion: 2008-12-02
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.